AMRN Just Got A Highly Anticipated FDA Approval!

Amarin stock remained halted late Friday after U.S. regulators approved its drug, Vascepa, to cut down on cardiovascular events in patients with high triglycerides.

This is the first Food and Drug Administration-approved medicine to lower the risk of events like a heart attack or stroke in patients with high triglycerides, a type of fat found in the blood. The agency approved Amarin's (AMRN) Vascepa in patients with triglycerides at 150 milligrams per deciliter or higher. A normal level is anything less than that.

"The FDA recognizes there is a need for additional medical treatments for cardiovascular disease," John Sharretts, acting deputy director of the Division of Metabolism and Endocrinology Products in the FDA's Center for Drug Evaluation and Research, said in a written statement.

所有跟帖： 

• 批准已经是HighlyAnticipated的了, 建议下周逢高减仓 -初进大观园- ♂ (0 bytes) () 12/13/2019 postreply 14:21:25

• 过节的礼物有了！ -arizona01- ♂ (0 bytes) () 12/13/2019 postreply 14:22:44

• 我也有些。这个股很奇怪，上次也是通过FDA 的什么，结果是大跌。但愿这次是向上走。 -1011a- ♂ (0 bytes) () 12/13/2019 postreply 14:27:47

• 有，有，有这事儿？完鸟。 -arizona01- ♂ (0 bytes) () 12/13/2019 postreply 14:34:38

• 别紧张，盘后巳经涨了块把了。 -1011a- ♂ (0 bytes) () 12/13/2019 postreply 14:43:34

• 但不知星期一如何动作。 -1011a- ♂ (0 bytes) () 12/13/2019 postreply 14:46:46

• 上次买弟兄喊后盈利一会。Dip后又买的。看周一吧，大观园说了，逢高卖。 -arizona01- ♂ (0 bytes) () 12/13/2019 postreply 14:57:10